Exagen News

Exagen | 10-Q: Quarterly report

SEC announcement49minutes ago · Announcements

Express News | Exagen Increases FY24 Revenue To At Least $55M Vs $54.160M Est

Benzinga08:46 ET

Earnings Flash (XGN) EXAGEN Reports Q1 Revenue $14.4M, Vs. Street Est of $13.1M

08:04 AM EDT, 05/13/2024 (MT Newswires) -- Earnings Flash (XGN) EXAGEN Reports Q1 Revenue $14.4M, vs. Street Est of $13.1M

MT Newswires08:04 ET

Exagen Raises 2024 Guidance >XGN

Exagen Raises 2024 Guidance >XGN

Dow Jones08:03 ET

Exagen: Existing Cash, Cash Equivalents Adequate to Meet Anticipated Cash Requirements Into 2026 >XGN

Exagen: Existing Cash, Cash Equivalents Adequate to Meet Anticipated Cash Requirements Into 2026 >XGN

Dow Jones08:03 ET

Express News | Exagen Inc: Sees FY24 Adjusted Ebitda Will Be Better Than Negative $18 Mln

Reuters08:02 ET

Express News | Exagen Inc: For Full Year 2024 Revenue, Increasing Our Guidance to at Least $55 Mln

Reuters08:02 ET

Express News | Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

Reuters08:00 ET

Express News | Exagen Inc. Q1 Net Income USD -3.36 Million Vs. Ibes Estimate USD -6.25 Million

Reuters08:00 ET

Express News | Exagen Inc. Q1 Gross Margin 59.6%

Reuters08:00 ET

Express News | Exagen Inc. Q1 Income From Operations USD -3.003 Million

Reuters08:00 ET

Express News | Exagen Inc. Q1 Operating Expenses USD 17.418 Million

Reuters08:00 ET

Express News | Exagen Inc. Q1 Revenue USD 14.415 Million Vs. Ibes Estimate USD 13.1 Million

Reuters08:00 ET

Express News | Exagen Inc. Q1 Basic EPS USD -0.19

Reuters08:00 ET

Express News | Exagen Inc. Outlook FY Revenue USD 55 Million

Reuters08:00 ET

Exagen 1Q Rev $14.4M >XGN

Exagen 1Q Rev $14.4M >XGN

Dow Jones08:00 ET

Press Release: Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune tes

Dow Jones08:00 ET

Exagen Announces Campaign for Lupus Awareness Month

CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign

GlobeNewswireMay 6 16:05 ET

Exagen to Announce First Quarter 2024 Results on May 13, 2024

CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before

GlobeNewswireApr 30 16:05 ET

Exagen: Brian Birk, Ebetuel Pallares, Wendy Johnson to Step Down From Board, Effective June 10 >XGN

Exagen: Brian Birk, Ebetuel Pallares, Wendy Johnson to Step Down From Board, Effective June 10 >XGN

Dow JonesApr 26 08:32 ET